MedTrace Logo

Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial

NCT05159765 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2025-09-22

No results posted yet for this study

Summary

This is a multi-center, randomized, double-masked clinical trial. All study devices are market approved/cleared in the localities where the study is conducted. Subjects will be randomly assigned to wear NaturalVue Sphere single vision contact lenses (SVCL) or NaturalVue Multifocal (NVMF) soft contact lenses for a total of three years.

Conditions

  • Myopia

Interventions

DEVICE

Single vision contact lenses

Wearing contact lenses during waking hours may alter the progression of myopia

DEVICE

Multifocal contact lenses

Wearing contact lenses during waking hours may alter the progression of myopia

Sponsors & Collaborators

  • Visioneering Technologies, Inc

    lead INDUSTRY

Principal Investigators

  • Ashley Tuan, OD, PhD · VTI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-22
Primary Completion
2026-02-28
Completion
2026-02-28
FDA Device
Yes

Countries

  • United States
  • Canada
  • Hong Kong
  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05159765 on ClinicalTrials.gov